DAI.AX stock is trading at A$0.345 intraday on the ASX on 19 Mar 2026, up 2.99% from yesterday. Decidr AI Industries Ltd (DAI.AX) mixes Australian beauty and nutraceutical sales with an AI software platform, leaving the market to price both hardware-like product revenue and high-growth software potential. Traders are watching liquidity—volume 495,268—and a 50-day average of A$0.45, as the stock trades well below its 52-week high A$1.14. Our analysis links these fundamentals and technicals to near-term catalysts and model-based forecasts.
DAI.AX stock: Intraday price and liquidity drivers
DAI.AX stock opened at A$0.32 and has traded between A$0.32 and A$0.35 today on the ASX. Volume is 495,268 versus an average of 737,662, leaving relative volume near 0.70 and indicating muted but meaningful intraday interest. Year-to-date the share price is down 43.90%, reflecting recent profit-taking and the market re-rating small-cap tech names.
DAI.AX stock: Fundamentals and valuation metrics
Decidr AI Industries reports EPS -0.16 and a trailing PE of -2.16, showing current losses while the company invests in product and platform development. Market capitalization stands at A$111,039,987 and shares outstanding are 321,855,034. Price-to-sales is steep at 57.35 and price-to-book is 14.69, signalling the market prices significant future growth into current valuation. Current ratio 0.84 and cash per share A$0.01 show tight short-term liquidity compared with peers in Technology.
DAI.AX stock: Technicals, momentum and short-term support
Technical indicators are mixed: RSI 36.02 and CCI -131.76 point to oversold short-term conditions, while ADX 34.26 signals a strong trend. Bollinger Bands sit at 0.45/0.41/0.36 (upper/middle/lower), placing the mid-band near immediate resistance. Short-term support is A$0.32 and intraday resistance is A$0.35; traders should watch a break above the 50-day average A$0.45 for trend confirmation.
Meyka AI rates DAI.AX with a score out of 100
Meyka AI rates DAI.AX with a score out of 100: 63.10 (Grade B) and a suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector and industry comparisons, financial growth, key metrics, forecasts, analyst consensus, and fundamental growth. The score reflects a mix of promising AI-sector opportunity and elevated valuation and liquidity risks. This grade is informational only and not investment advice.
DAI.AX stock: Forecasts, price targets and analyst-style outlook
Meyka AI’s forecast model projects monthly A$0.36, quarterly A$1.18, and yearly A$2.22 versus the current price A$0.345. That implies upside of 4.35% (monthly), 242.03% (quarterly) and 543.48% (yearly). Short-term target: A$0.36; 12-month base case: A$2.22. Forecasts assume successful AI product rollouts and improved software margins. Forecasts are model-based projections and not guarantees.
DAI.AX stock: Key risks and potential catalysts
Primary risks are tight liquidity, negative EPS, and high valuation multiples (P/S 57.35, P/B 14.69). Catalysts include product adoption for the AI platform, improved margins in the beauty and nutraceutical business, and the next earnings release scheduled 28 Aug 2026. Regulatory or execution setbacks in AI deployment would quickly pressure the share price. Monitor trading volume and operating cash flow per share -0.02 for signs of runway pressure.
Final Thoughts
DAI.AX stock trades at A$0.345 on the ASX and presents a high-risk, high-reward profile for AI-focused investors. Fundamentals show negative EPS -0.16 and tight liquidity, while technicals indicate oversold conditions but a continuing downtrend versus the 50- and 200-day averages. Meyka AI’s forecast model projects A$2.22 in 12 months, implying 543.48% upside from A$0.345, but that projection relies on strong execution and revenue mix improvement. Our proprietary grade (B, score 63.10) balances the growth narrative against valuation and cash-flow risks. For traders, a conservative approach is to wait for a confirmed break above A$0.45 (50-day average) or clearer revenue traction in the AI segment. For longer-term investors, allocate small exposure only after due diligence and readiness for high volatility. Meyka AI provides this AI-powered market analysis to clarify scenarios; forecasts are model-based projections and not guarantees.
FAQs
What is the current DAI.AX stock price and trading range today?
DAI.AX stock is trading at A$0.345 intraday (19 Mar 2026). Today’s range is A$0.32 to A$0.35 with volume 495,268, below the 50-day average of A$0.45.
Is DAI.AX stock a buy right now?
DAI.AX stock is a speculative buy for growth-focused investors who accept high volatility and execution risk. Meyka AI gives a Grade B (HOLD); wait for improved cash flow or a breakout above A$0.45 before increasing position size.
What are the main catalysts for DAI.AX stock?
Key catalysts for DAI.AX stock include stronger AI platform revenue, margin expansion in the beauty/nutraceutical segment, higher sales traction, and a positive earnings report on 28 Aug 2026.
How does Meyka AI forecast DAI.AX stock performance?
Meyka AI’s forecast model projects A$0.36 (monthly), A$1.18 (quarterly) and A$2.22 (yearly) against the current price A$0.345. These are model-based projections and not guarantees.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)